相关实验视频
Updated: Jul 17, 2025

09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
21.7K
痴呆症患者的整体和因特定死亡率:台湾的一项基于人口的队列研究
Chia-Lun Kuo1,2, Pei-Chen Lee1, Li-Jung Elizabeth Ku1
1Department of Public Health, National Cheng Kung University College of Medicine, Tainan, Taiwan.
Epidemiology and health
|September 1, 2023
概括
循环和呼吸系统疾病是痴呆症患者 (PWD) 死亡的主要原因. 年轻的PWD面临更高的死亡风险,特别是来自神经系统和精神障碍,需要专注的医疗照顾.
科学领域:
- 老年学与公共卫生
- 神经学和精神病学 精神病学
背景情况:
- 了解痴呆症患者的死亡原因和死亡率对于有效的医疗策略至关重要.
- 台湾的国家数据集为分析痴呆相关死亡率模式提供了坚实的基础.
研究的目的:
- 确定台湾PWD的主要潜在死亡原因 (UCODs).
- 估计PWD的整体和特定原因的标准化死亡率 (SMR).
主要方法:
- 利用了台湾死亡登记和国家健康保险医疗索赔的数据.
- 计算了观察到的人-年和特定于性别,特定于年龄的SMR,直到2016年底.
主要成果:
- 循环系统疾病 (26.0%) 和呼吸系统疾病 (21.3%) 是PWD的主要UCOD.
- 患有PWD的人群的全因死亡风险增加了2.01倍,神经系统疾病 (7.58) 和精神障碍 (4.80) 的SMR更高.
- 死亡率风险 (SMR) 随着年龄的增长而降低,并且在大多数原因中在年轻的PWD中更高.
结论:
- 循环和呼吸道疾病是PWD的主要UCOD.
- 建议增加神经学和精神病学服务的资源,因为相关疾病的死亡率高.
- 年轻的PWD需要加大临床注意力,因为由于各种原因的死亡风险增加.
更多相关视频
07:42Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
3.0K
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
32.4K
相关概念视频
Dementia
139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
139
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212